3. Gong FM, Peng XC, Tan BX, Ge J, Chen X, Chen Y, Xu F, Bi F, Hou JM, Liu JY. Comparative proteomic analysis of irinotecan-sensitive colorectal carcinoma cell line and its chemoresistant counterpart. Anticancer Drugs. 2011 Jul;22(6):500-6. PubMed PMID: 21637159. （通訊作者)
4. Zhao Y, Cheng K, Wu Y, Peng XC, Chen Y, Tan BX, Ge J, Dong H, Wei M, Gao F, Su JM, Hou JM, Liu JY. Interleukin-15 enhances T-cell responses by stimulation with dendritic cells. Clin Transl Oncol. 2011 Apr;13(4):275-80. PubMed PMID: 21493189. （通訊作者)
5. Peng XC, Gong FM, Wei M, Chen X, Chen Y, Cheng K, Gao F, Xu F, Bi F, Liu JY. Proteomic analysis of cell lines to identify the irinotecan resistance proteins. J Biosci. 2010 Dec;35(4):557-64.（通訊作者)
6. Ge J, Tan BX, Chen Y, Yang L, Peng XC, Li HZ, Lin HJ, Zhao Y, Wei M, Cheng K, Li LH, Dong H, Gao F, He JP, Wu Y, Qiu M, Zhao YL, Su JM, Hou JM, Liu JY. Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. J Mol Med. 2011 Jun;89(6):595-602. Epub 2011 Feb 18. PMID: 21331509（通訊作者)
7. Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, Niu T, Liu F, Jiang Y, Hu B, Wu Y, Su JM, Lou YY, He QM, Wen YJ, Yang JL, Kan B, Mao YQ, Luo F, Peng F. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth
gydjdsj.org.cn factor receptor-2. Blood. 2003 Sep 1;102(5):1815-23. Epub 2003 May 15. PubMed PMID: 12750177.
8. Liu JY, Wu Y, Zhang XS, Yang JL, Li HL, Mao YQ, Wang Y, Cheng X, Li YQ, Xia JC, Masucci M, Zeng YX. Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine. Cancer Immunol Immunother. 2007 Oct;56(10):1597-604. Epub 2007 Apr 18. PubMed PMID: 17440723.
9. Liu JY, Zhang XS, Ding Y, Peng RQ, Cheng X, Zhang NH, Xia JC, Zeng YX. The changes of CD4+CD25+/CD4+ proportion in spleen of tumor-bearing BALB/c mice. J Transl Med. 2005 Jan 28;3(1):5. PubMed PMID: 15679891; PubMed Central PMCID:15679891.
聯(lián)系方式:電話： 028－85423262 郵箱:liujiyan1972@163.com
上一頁 [1] [2] [3] 下一頁
